Treatment of Generalized Tonic-Clonic Seizures in the Modern Era

Slides:



Advertisements
Similar presentations
Moderate-to-Severe Asthma Management
Advertisements

Immunotherapies: Key Considerations in the Identification and Management of irAEs.
Current Management and Future Options for Tardive Dyskinesia
Clinical Trials in IBD.
New Psoriasis Treatments
Psoriatic Arthritis.
Pharmaceutical- vs Dispensary-Sourced Cannabinoids
Improving the Diagnosis and Treatment of Seizures in Long-term Care
Advances in Managing Inhibitors in Patients With Hemophilia A
Exploring the Spectrum of Excessive Daytime Sleepiness
Pseudomonas Lung Infections in Cystic Fibrosis
Progression After Cancer Immunotherapy in Advanced NSCLC
Pediatric Antiepileptic Treatment Strategies
Epilepsy Treatment Across the Spectrum
Reducing Postoperative Ileus
Understanding the Many Faces of Pseudobulbar Affect
Clues to a Diagnosis: A Focus on Light-Chain Amyloidosis
Ask the Onychomycosis Expert, Part 2
Ask the Onychomycosis Expert, Part 1
Standards of Care in Duchenne Muscular Dystrophy: A 2018 Update
Improving Acne Outcomes
Neurostimulation for the Management of Medication-Resistant Epilepsy
Case Challenges in Chronic Migraine
Updates in Management of Atopic Dermatitis From Real Patient Cases
Definitions: Seizure, Epilepsy, Epilepsy Syndrome
Advances in Dry Eye.
Before and After: Patient Cases in Onychomycosis
Assessing Newer Treatment Approaches for Multiply Relapsed Multiple Myeloma.
BTK Inhibitors in Relapsed/Refractory Mantle Cell Lymphoma
Aligning Patients and Clinicians: Optimizing Outcomes in Metastatic NSCLC.
Chronic Idiopathic Urticaria
Addressing Disease Burden in Asthma
Seizures in the Elderly: Treatment and Special Considerations
Nontuberculous Mycobacterial Lung Disease
Case Studies in Unresectable Hepatocellular Carcinoma
Gene Therapy: Past, Present, and Future
Tackling Atopic Dermatitis
Expert Debate in MDD.
Immunotherapy for cSCC
CGRP Antibodies in Migraine
Optimizing Frontline Care for Older Patients With Multiple Myeloma
Diagnosing Focal Epilepsy: A Clinical Case
Best Practices in the Clinical Management of Motor Symptoms Associated With Huntington Disease.
When Is Biologic Therapy Appropriate for HS?
Expert Insights Into the Latest Treatment of Advanced Soft-Tissue Sarcoma.
Personalizing Management in the Care of Patients With Advanced Sarcoma
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Expert Perspectives on the Clinical Use of Immune Reconstitution vs Escalation Therapy for MS.
Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.
Parkinson Disease Psychosis
Talking With Your Patients About Excessive Sweating
Advances in Immunotherapy for Peanut Allergy
Guide to Atopic Dermatitis
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Considerations in Managing Seizures in Women
Patient Questions and Expert Answers in Psoriasis:
Evaluating BTK Inhibitors in CLL
Expert Perspectives in the Recognition and Management of Lennox-Gastaut Syndrome.
Pregnancy in MS.
Novel Concepts in the Management of RCC
From Adjuvant to Metastatic in Melanoma
Program Goal. Program Goal Disclaimer Overview.
This program will include a discussion of off-label treatment or use of investigational agents not approved by the FDA for use in the US, and data that.
Issues in Patients With Severe Epilepsy
Checkpoint Inhibitors in First-Line Advanced NSCLC
VKA Reversal and LVADs.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.
Empowering Patients and Prescribers to Improve Treatment Adherence in Schizophrenia.
Foundations of Asthma.
Presentation transcript:

Treatment of Generalized Tonic-Clonic Seizures in the Modern Era

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US.

2017 ILAE Epilepsy Nomenclature

Most Common IGE Syndromes

DRE at UK Epilepsy Referral Clinics

Case 1

Case 1: Care by a General Neurologist

Case 1: Testing, Results, and Diagnosis

Importance of Referral

Apparent Drug Resistance in IGE

Treatment Goals in IGE

Expert Opinion Survey: Design

Expert Opinion Survey: Treatment of IGE With GTCS First Monotherapy

Expert Opinion Survey: Treatment of IGE With GTCS First Monotherapy (cont)

Expert Opinion Survey: Initial AED Selection*

Expert Review: AEDs of Choice

Perampanel: FDA Approved for GTCS

Other Drugs Used for the Treatment of GTCS

Case 2: General History

Case 2: Seizure History

Case 2: Findings and Diagnosis

Case 2: Treatment Considerations

Case 2: Selecting AEDs

Case 2: Treatment Options First Monotherapy

Case 2: Treatment Options First Monotherapy (cont)

Case 2: Treatment Options First Monotherapy (cont)

Case 2: Treatment Options First Monotherapy (cont)

Case 2: Treatment Options First Monotherapy (cont)

Case 2: Treatment Selection

North American AED Pregnancy Registry

Basis of Uncontrolled Seizures With First-Line AED

Case 3: History

Case 3: Selecting AED in DRE

Treating DRE

Conclusions

Abbreviations

Abbreviations